Literature DB >> 3874081

Inhibition of [3H]thymidine incorporation by Mycoplasma arginini-infected cells due to enzymatic cleavage of the nucleoside.

F Sinigaglia, K W Talmadge.   

Abstract

Culture supernatants contaminated by Mycoplasma arginini inhibit the incorporation of [3H]thymidine ([3H]dThd) by cytotoxic T lymphocyte cell lines. This study presents evidence that the inhibition of uptake of the nucleoside is due to the rapid cleavage of the exogenous [3H]dThd into thymine. Uridine and cytidine as well as dThd are degraded by the mycoplasma-contaminated supernatants, while no cleavage was observed with uninfected supernatants. Cells contaminated by mycoplasma apparently release a pyrimidine-specific nucleosidase, possibly a dThd phosphorylase, which is responsible for the inhibition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874081     DOI: 10.1002/eji.1830150710

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination.

Authors:  M Merkenschlager; D Kardamakis; F C Rawle; N Spurr; P C Beverley
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

2.  Cellular delivery of nucleoside diphosphates: a prodrug approach.

Authors:  S H Kang; A K Sinhababu; J G Cory; B S Mitchell; D R Thakker; M J Cho
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

Review 3.  Immunobiology of complete molar pregnancy and gestational trophoblastic tumor.

Authors:  R S Berkowitz; S A Umpierre; S Taylor-Emery; D P Goldstein; D J Anderson
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

4.  Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine.

Authors:  Florence Perillo-Adamer; Angelika Bischof Delaloye; Céline S Genton; Andreas O Schaffland; Yves M Dupertuis; Franz Buchegger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

5.  Induction of antitumor activity in macrophages by mycoplasmas in concert with interferon.

Authors:  K Uno; M Takema; S Hidaka; R Tanaka; T Konishi; T Kato; S Nakamura; S Muramatsu
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT.

Authors:  Szeman Ruby Chan; Kelley Salem; Justin Jeffery; Ginny L Powers; Yongjun Yan; Kooresh I Shoghi; Aparna M Mahajan; Amy M Fowler
Journal:  J Nucl Med       Date:  2017-12-07       Impact factor: 10.057

7.  Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.

Authors:  A Meyerhans; J P Vartanian; C Hultgren; U Plikat; A Karlsson; L Wang; S Eriksson; S Wain-Hobson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.

Authors:  Johan Vande Voorde; Suna Sabuncuoğlu; Sam Noppen; Anders Hofer; Farahnaz Ranjbarian; Steffen Fieuws; Jan Balzarini; Sandra Liekens
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

9.  Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro.

Authors:  Severin Zinöcker; Meng-Yu Wang; Peter Gaustad; Gunnar Kvalheim; Bent Rolstad; John T Vaage
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

Review 10.  Mycoplasmas and cancer: focus on nucleoside metabolism.

Authors:  Johan Vande Voorde; Jan Balzarini; Sandra Liekens
Journal:  EXCLI J       Date:  2014-03-27       Impact factor: 4.068

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.